1. Home
  2. RNAC vs RAPP Comparison

RNAC vs RAPP Comparison

Compare RNAC & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cartesian Therapeutics Inc.

RNAC

Cartesian Therapeutics Inc.

HOLD

Current Price

$9.07

Market Cap

204.6M

Sector

Health Care

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$29.87

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNAC
RAPP
Founded
2007
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
204.6M
1.2B
IPO Year
2016
2024

Fundamental Metrics

Financial Performance
Metric
RNAC
RAPP
Price
$9.07
$29.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$38.40
$47.80
AVG Volume (30 Days)
196.3K
368.1K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,091,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.98
$6.43
52 Week High
$23.93
$42.27

Technical Indicators

Market Signals
Indicator
RNAC
RAPP
Relative Strength Index (RSI) 67.04 59.79
Support Level $6.66 $28.03
Resistance Level $8.40 $31.00
Average True Range (ATR) 0.57 1.83
MACD 0.28 0.11
Stochastic Oscillator 95.19 72.79

Price Performance

Historical Comparison
RNAC
RAPP

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: